Quest Laboratories Financial Statements
Quest Laboratories financial statements. In FY2026, Quest Laboratories (QUESTLAB) reported revenue ₹114 Cr, net profit ₹15 Cr and EPS ₹9.07, with a net profit margin of 13.2% and ROE of 15.5%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse QUESTLAB shareholder distribution to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
QUESTLAB Revenue, Net Profit & EBITDA — Year-on-Year Growth
QUESTLAB YoY (March 2025 vs March 2026) — revenue +5.6%, net profit +7.1%, EBITDA +5.0%, expenses +6.8%. For live price, earnings ratios and company overview, see Quest Laboratories screener.
QUESTLAB Income Statement — Revenue, EBITDA & Net Profit
Quest Laboratories revenue ₹114 Cr, EBITDA ₹21 Cr, net profit ₹15 Cr, EPS ₹9.07 (2026) — net profit margin 13.2%. Read QUESTLAB dividend yield for the complete payout history and dividend yield track record.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|
| Revenue | 114 | 108 | 83 | 62 | 60 | 30 |
| Expenses | 94 | 88 | 67 | 54 | 53 | 29 |
| EBITDA | 21 | 20 | 16 | 8 | 7 | 2 |
| Operating Profit Margin % | 16.00% | 15.00% | 19.00% | 13.00% | 11.00% | 5.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 2 | 1 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 18 | 19 | 14 | 7 | 6 | 1 |
| Tax | 3 | 5 | 4 | 2 | 2 | 0 |
| Net Profit | 15 | 14 | 10 | 5 | 4 | 1 |
| Earnings Per Share (₹) | 9.07 | 8.28 | 6.16 | 46.76 | 38.05 | 6.07 |
QUESTLAB Balance Sheet — Assets, Liabilities & Shareholders' Equity
QUESTLAB total assets ₹112 Cr, total equity ₹97 Cr, total liabilities ₹ Cr (2026) — ROE 15.5%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 112 | 122 | 61 | 47 | 35 | 18 |
| Current Assets | 93 | 107 | 50 | 34 | 27 | 12 |
| Fixed Assets | 15 | 12 | 10 | 10 | 7 | 6 |
| Capital Work in Progress | 2 | 0 | 0 | 0 | 0 | 0 |
| Investments | 16 | 52 | 7 | 0 | 0 | 0 |
| Other Assets | 80 | 58 | 44 | 37 | 27 | 13 |
| LIABILITIES | ||||||
| Total Liabilities | ||||||
| Current Liabilities | 2 | 3 | 2 | 3 | 2 | 2 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 97 | 82 | 29 | 15 | 10 | 6 |
| Share Capital | 16 | 16 | 12 | 1 | 1 | 1 |
| Reserves & Surplus | 80 | 65 | 17 | 14 | 9 | 5 |
QUESTLAB Cash Flow Statement — Operating, Investing & Financing
Quest Laboratories operating cash flow ₹-11 Cr, investing ₹35 Cr, financing ₹-24 Cr, net cash flow ₹0 Cr (2026).
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|
| Operating Activities | -11 | -23 | 3 | 4 | 4 | 1 |
| Investing Activities | 35 | -44 | -5 | -4 | -2 | -1 |
| Financing Activities | -24 | 67 | 2 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 0 |